| 000 | 01748 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516150605.0 | ||
| 264 | 0 | _c20140311 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1399-0012 | ||
| 024 | 7 |
_a10.1111/ctr.12129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaliba, Faouzi | |
| 245 | 0 | 0 |
_aFungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. _h[electronic resource] |
| 260 |
_bClinical transplantation _c |
||
| 300 |
_aE454-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCandida _xisolation & purification |
| 650 | 0 | 4 |
_aCandidiasis, Invasive _xdrug therapy |
| 650 | 0 | 4 |
_aEnd Stage Liver Disease _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHospital Mortality _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aDelvart, Valérie | |
| 700 | 1 | _aIchaï, Philippe | |
| 700 | 1 | _aKassis, Najiby | |
| 700 | 1 | _aBotterel, Françoise | |
| 700 | 1 | _aMihaila, Liliana | |
| 700 | 1 | _aAzoulay, Daniel | |
| 700 | 1 | _aAdam, René | |
| 700 | 1 | _aCastaing, Denis | |
| 700 | 1 | _aBretagne, Stéphane | |
| 700 | 1 | _aSamuel, Didier | |
| 773 | 0 |
_tClinical transplantation _gvol. 27 _gno. 4 _gp. E454-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ctr.12129 _zAvailable from publisher's website |
| 999 |
_c22734412 _d22734412 |
||